ARCHIVES

FPD-R Regimen Well-Tolerated, With 63 Percent Complete Response

This article is from The Cancer Letter archive.

Vol. 34 No. 7 | July 29, 2011

Download PDF Visit The Full Archive

Related Articles

Inhibitor Reduces Spleen Size By 35 Percent or More in Phase III

June 28, 2013

Protocols Approved During the Month of June 2002

July 26, 2002

UT-Houston Wins NIH Center Grant For Alternative Cancer Medicine Studies

November 3, 1995

Blueprint Group co-chairman Mark Ratain says group seeks “the perfect peer review system,” but a member’s email questions the proposal.

August 13, 2004

In Brief: General Motors Cancer Prizes Awarded; Thomas Promoted; HIV Research funding

June 24, 1994

Analysis Shows No Mortality Benefit From Regular PSA Screening

January 27, 2012